Cite
HARVARD Citation
Bachelet, T. et al. (2015). Intravenous immunoglobulins and rituximab therapy for severe transplant glomerulopathy in chronic antibody‐mediated rejection: a pilot study. Clinical transplantation. pp. 439-446. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bachelet, T. et al. (2015). Intravenous immunoglobulins and rituximab therapy for severe transplant glomerulopathy in chronic antibody‐mediated rejection: a pilot study. Clinical transplantation. pp. 439-446. [Online].